echocardiographic evaluation of prosthetic heart valves patricia tung, m.d. february 10, 2010
TRANSCRIPT
Echocardiographic Echocardiographic Evaluation of Prosthetic Evaluation of Prosthetic
Heart ValvesHeart Valves
Patricia Tung, M.D.Patricia Tung, M.D.
February 10, 2010February 10, 2010
ObjectivesObjectives
Types of prosthesesTypes of prostheses Prosthetic dysfunctionProsthetic dysfunction Echocardiographic surveillance of Echocardiographic surveillance of
prosthesesprostheses
Types of ProsthesesTypes of Prostheses
Mechanical valvesMechanical valves Tissue valvesTissue valves Homograft valvesHomograft valves
Mechanical ValvesMechanical Valves
Tissue ValvesTissue Valves
Homograft ValvesHomograft Valves
ObjectivesObjectives
Types of prosthesesTypes of prostheses Prosthetic dysfunctionProsthetic dysfunction Echocardiographic surveillance of Echocardiographic surveillance of
prosthesesprostheses
Mechanisms of Prosthetic Valve Mechanisms of Prosthetic Valve DysfunctionDysfunction
Structural failureStructural failure StenosisStenosis RegurgitationRegurgitation
Thromboembolic complicationsThromboembolic complications EndocarditisEndocarditis Patient Prosthesis MismatchPatient Prosthesis Mismatch
Structural Failure BioprostheticsStructural Failure Bioprosthetics
Cohn et al. Ann Thorac Surg, 1998.
Homograft DysfunctionHomograft Dysfunction
Subject to severe tissue calcification Subject to severe tissue calcification Usually reserved for complex aortic root Usually reserved for complex aortic root
abscessesabscesses Hyperlipidemia accelerates prosthesis Hyperlipidemia accelerates prosthesis
calcificationcalcification Secondary prevention may slow this Secondary prevention may slow this
process process
Physical Exam FindingsPhysical Exam Findings
TTETTE valve area and regurgitationvalve area and regurgitation exclude significant obstruction exclude significant obstruction Flow velocity is crucial measurementFlow velocity is crucial measurement Often inadequate for infection or small structural changes (strut fracture, small Often inadequate for infection or small structural changes (strut fracture, small
vegetation, paravalvular leak)vegetation, paravalvular leak)
TEETEE inspection of valve apparatus and seatinginspection of valve apparatus and seating may not accurately quantify valve flow velocitiesmay not accurately quantify valve flow velocities
Echocardiographic EvaluationEchocardiographic Evaluation
Normal Appearance PVNormal Appearance PV
Normal Doppler ClicksNormal Doppler Clicks
Normal Doppler Flow PatternsNormal Doppler Flow Patterns
Fluid Dynamics and VelocitiesFluid Dynamics and Velocities
Normal Finding: RegurgitationNormal Finding: Regurgitation
Pathologic RegurgitationPathologic Regurgitation
Characterized by:Characterized by: An eccentric or large jetAn eccentric or large jet Marked variance on the color flow displayMarked variance on the color flow display A jet that originates around the valve sewing A jet that originates around the valve sewing
ringring Visualization of a proximal flow acceleration Visualization of a proximal flow acceleration
region on the LV side of the mitral valveregion on the LV side of the mitral valve
Prosthetic Valve RegurgitationProsthetic Valve Regurgitation
Prosthetic Valve StenosisProsthetic Valve Stenosis
Pressure gradientsPressure gradients- Calculated using the Bernoulli equation (4vCalculated using the Bernoulli equation (4v22))- Good correlation when validated against Good correlation when validated against
invasive pressure measurementsinvasive pressure measurements- mechanical valves, especially bileaflet, result mechanical valves, especially bileaflet, result
in overestimation of the gradient due to in overestimation of the gradient due to differing fluid dynamics differing fluid dynamics
Prosthetic Aortic Valve AreaProsthetic Aortic Valve Area
Prosthetic AVA: Velocity RatioProsthetic AVA: Velocity Ratio
Measure velocity increase across valveMeasure velocity increase across valve Ratio of outflow tract velocity/aortic jet Ratio of outflow tract velocity/aortic jet
velocity reflects degree of stenosisvelocity reflects degree of stenosis Ratio = 1 if no obstruction presentRatio = 1 if no obstruction present Given inherent stenosis, normal range is Given inherent stenosis, normal range is
0.35 to 0.5 for aortic prosthesis0.35 to 0.5 for aortic prosthesis
Prosthetic Mitral Valve AreaProsthetic Mitral Valve Area
Can be estimated using the pressure half-Can be estimated using the pressure half-time approach as for native mitral valve time approach as for native mitral valve stenosis.stenosis.
The expected half-time for a PV is longer The expected half-time for a PV is longer than with a native valve.than with a native valve.
Prosthetic Valve ThrombosisProsthetic Valve Thrombosis
TEE is often negative if the TEE is often negative if the thrombi are small or if new thrombi are small or if new thrombus has not formed thrombus has not formed since the initial embolic since the initial embolic event.event.
Thus an embolic event in a Thus an embolic event in a patient with a prosthetic patient with a prosthetic valve (esp mechanical) valve (esp mechanical) must be presumed to be must be presumed to be related to the PV even if the related to the PV even if the TEE is negative.TEE is negative.
Prosthetic Valve EndocarditisProsthetic Valve Endocarditis
Difficult to detect with TTEDifficult to detect with TTE Often involves sewing ring and annulus, Often involves sewing ring and annulus,
resulting in paravalvular abscess rather resulting in paravalvular abscess rather than a discrete vegetationthan a discrete vegetation
Prosthetic Valve EndocarditisProsthetic Valve Endocarditis
Patient Prosthesis MismatchPatient Prosthesis Mismatch
Size of prosthesis results in inadequate Size of prosthesis results in inadequate blood flow given metabolic demandsblood flow given metabolic demands
Prosthesis itself functions wellProsthesis itself functions well Indexed effective orifice area < or = Indexed effective orifice area < or =
0.85cm2/m20.85cm2/m2 Predicts high transvalvular gradients, Predicts high transvalvular gradients,
persistent LVH and increased rate of persistent LVH and increased rate of cardiac events following AVRcardiac events following AVR
ObjectivesObjectives
Types of prosthesesTypes of prostheses Prosthetic dysfunctionProsthetic dysfunction Echocardiographic surveillance of Echocardiographic surveillance of
prosthesesprostheses
Recommended SurveillanceRecommended Surveillance Baseline echocardiogram 6-8 weeks Baseline echocardiogram 6-8 weeks
postoperativelypostoperatively Routine echocardiographic surveillance Routine echocardiographic surveillance
annually thereafterannually thereafter Evaluate forEvaluate for
Regression of hypertrophy or dilationRegression of hypertrophy or dilation Recovery of LV systolic functionRecovery of LV systolic function Changes in PA pressuresChanges in PA pressures
SummarySummary Prosthetic valve dysfunction is well detected by Prosthetic valve dysfunction is well detected by
echocardiographyechocardiography Dysfunction includesDysfunction includes
Structural failureStructural failure Thromboembolic complicationsThromboembolic complications EndocarditisEndocarditis PPMPPM
Distinguishing normal from pathologic function Distinguishing normal from pathologic function can be challenging; most useful is comparison to can be challenging; most useful is comparison to baseline post-prosthesis baseline post-prosthesis
ReferencesReferences Otto, C. Textbook of Clinical Echocardiography, Fourth Edition Otto, C. Textbook of Clinical Echocardiography, Fourth Edition
2009.2009. Libby et al. Braunwald’s Heart Disease. Eighth Edition 2008.Libby et al. Braunwald’s Heart Disease. Eighth Edition 2008. Pibarot, P and Dumesnil JG. Prosthesis-patient mismatch: Pibarot, P and Dumesnil JG. Prosthesis-patient mismatch:
definition, clinical impact, and prevention. Heart 2006;92:1022-1029 definition, clinical impact, and prevention. Heart 2006;92:1022-1029 Bonow RO, Carabello BA, Chatterjee K, et al: ACC/AHA 2006 Bonow RO, Carabello BA, Chatterjee K, et al: ACC/AHA 2006
guidelines for the management of patients with valvular heart guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): Developed in collaboration Patients with Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. the Society of Thoracic Surgeons. CirculationCirculation 2006; 114:e84. 2006; 114:e84.